Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103535
Filing Date
2025-08-06
Accepted
2025-08-06 07:15:26
Documents
106
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-20250630.htm   iXBRL 10-Q 3837021
2 EX-10.1 mnkd-ex10_1.htm EX-10.1 80628
3 EX-10.2 mnkd-ex10_2.htm EX-10.2 1645736
4 EX-31.1 mnkd-ex31_1.htm EX-31.1 15331
5 EX-31.2 mnkd-ex31_2.htm EX-31.2 15330
6 EX-32.1 mnkd-ex32_1.htm EX-32.1 11040
7 EX-32.2 mnkd-ex32_2.htm EX-32.2 11048
  Complete submission text file 0000950170-25-103535.txt   19255337

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250630.xsd EX-101.SCH 2537056
109 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250630_htm.xml XML 3464279
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 251187436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)